This company has been marked as potentially delisted and may not be actively trading. NASDAQ:NXTM NxStage Medical (NXTM) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About NxStage Medical Stock (NASDAQ:NXTM) 30 days 90 days 365 days Advanced Chart Get NxStage Medical alerts:Sign Up Key Stats Today's Range$29.98▼$30.0050-Day Range$30.00▼$30.0052-Week Range$23.17▼$30.00Volume2.61 million shsAverage Volume1.51 million shsMarket Capitalization$2.00 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. The company operates through three segments: System One, In-Center, and Services. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment, as well as sells disposable products in the home and critical care market for the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting and in the critical care market for the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers, and needles for apheresis. The Services segment offers dialysis services to patients at NxStage Kidney Care dialysis centers. As of February 3, 2018, it had 21 centers. NxStage Medical, Inc. markets its products through direct sales to dialysis clinics and hospitals in the United States, the United Kingdom, and Canada, as well as through distributors in Europe and internationally. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.Read More… Receive NXTM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NxStage Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address NXTM Stock News HeadlinesNextcom Ltd.July 21, 2023 | wsj.comNXTM.TA - Nextcom Ltd. | Stock Price & Latest News | ReutersSeptember 23, 2022 | reuters.comWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."May 8, 2025 | Brownstone Research (Ad)Omnicell to Buy Ateb, Expand in Adherence Tools MarketOctober 26, 2021 | finance.yahoo.comSee More Headlines NXTM Stock Analysis - Frequently Asked Questions How were NxStage Medical's earnings last quarter? NxStage Medical, Inc. (NASDAQ:NXTM) issued its quarterly earnings data on Monday, August, 7th. The medical device company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by $0.00. NxStage Medical's revenue for the quarter was up .0% compared to the same quarter last year. What other stocks do shareholders of NxStage Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that NxStage Medical investors own include Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW) and Athabasca Oil (ATH). Company Calendar Last Earnings8/07/2017Today5/07/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical Equipment Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:NXTM CIK1333170 Webwww.nxstage.com Phone978-687-4700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,470,000.00 Net Margins-1.29% Pretax MarginN/A Return on Equity-2.50% Return on Assets-1.60% Debt Debt-to-Equity RatioN/A Current Ratio3.60 Quick Ratio2.69 Sales & Book Value Annual Sales$393.94 million Price / Sales5.08 Cash Flow$0.29 per share Price / Cash Flow103.07 Book Value$3.22 per share Price / Book9.32Miscellaneous Outstanding Shares66,680,000Free FloatN/AMarket Cap$2.00 billion OptionableOptionable Beta0.25 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:NXTM) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredNew breed of trader (Wall Street hates us?)Wall Street big wigs and old-money bankers can’t touch this 1 type of stock. And that opens the door for tr...Timothy Sykes | Sponsored270x more lucrative than NVIDIA???270x more lucrative than NVIDIA??? If you've missed out on NVIDIA's recent 1,600% run... Don't worry. ...Behind the Markets | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NxStage Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NxStage Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.